| Plasticity of ether lipids promotes ferroptosis susceptibility and evasion Y Zou, WS Henry, EL Ricq, ET Graham, VV Phadnis, P Maretich, ... Nature 585 (7826), 603-608, 2020 | 482 | 2020 |
| Development of curcumin-loaded solid lipid nanoparticles utilizing glyceryl monostearate as single lipid using QbD approach: characterization and evaluation of anticancer … H Bhatt, SVK Rompicharla, N Komanduri, S Aashma, S Paradkar, ... Current drug delivery 15 (9), 1271-1283, 2018 | 34 | 2018 |
| Setdb1-loss induces type-I interferons and immune clearance of melanoma MK McGeary, W Damsky, A Daniels, E Song, G Micevic, C Calderwood, ... bioRxiv, 2023.05. 23.541922, 2023 | 2 | 2023 |
| Creation of a new class of radiosensitizers for glioblastoma based on the mibefradil pharmacophore S Paradkar, J Herrington, A Hendricson, P Hewawasam, M Plummer, ... Oncotarget 12 (9), 891, 2021 | 1 | 2021 |
| Exploiting Metabolic Defects in Glioma with Nanoparticle Encapsulated NAMPT Inhibitors MA Murray, KJ Noronha, Y Wang, AP Friedman, S Paradkar, HW Suh, ... Molecular Cancer Therapeutics, 2024 | | 2024 |
| NAPRT silencing in oncometabolite-producing cancers confers therapeutic vulnerabilities to NAD+ depletion KJ Noronha, KN Lucas, SJ Zhao, J Edmonds, S Friedman, MA Murray, ... Cancer Research 84 (6_Supplement), 3086-3086, 2024 | | 2024 |
| Abstract B051: PARG inhibition leads to the formation of toxic nuclear PARP1 aggregates S Paradkar, A Cui, J Purcell, S Friedman, R Jensen, R Bindra Molecular Cancer Therapeutics 22 (12_Supplement), B051-B051, 2023 | | 2023 |
| PARG inhibition induces nuclear aggregation of PARylated PARP1 S Paradkar, J Purcell, A Cui, S Friedman, R Sundaram, RB Jensen, ... bioRxiv, 2023.08. 12.553088, 2023 | | 2023 |
| Setdb1-loss reactivates ERV expression and interferon signaling to induce immune-mediated melanoma clearance MK McGeary, W Damsky, D Daniels, G Micevic, E Song, HJ Lou, ... Cancer Research 82 (12_Supplement), 1380-1380, 2022 | | 2022 |
